Literature DB >> 13680435

Wechsler Adult Intelligence Scale-Third Edition findings in relation to severity of brain injury in litigants.

Pauline M Langeluddecke1, Sara K Lucas.   

Abstract

WAIS-III findings were reported for 150 litigants, classified into three groups according to severity of traumatic brain injury (TBI), and a general population control group. There was a significant "dose response" relationship between TBI severity and all Index/IQ scores. Effect size was greatest for the Processing Speed Index (PSI). Between group differences were significant on all subtests except Information and Digit Span. Effect sizes were greatest for Digit Symbol, Symbol Search, Similarities, and Picture Arrangement. Relative to the control group, there was a significant difference for the Severe and Extremely Severe TBI groups on all IQ/Index scores and most subtests. The Moderate TBI group differed significantly on one Index (the PSI) and none of the subtests. Clinical implications of the findings are discussed in relation to the utility of the WAIS-III in assessing the cognitive sequelae of TBI, the use of current WAIS-III IQ scores to assess intelligence-memory discrepancies, WAIS-III short forms, and estimation of premorbid intelligence.

Entities:  

Mesh:

Year:  2003        PMID: 13680435     DOI: 10.1076/clin.17.2.273.16499

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  2 in total

1.  The effect of premorbid demographic factors on the recovery of neurocognitive function in traumatic brain injury patients.

Authors:  Ik-Chan Jeon; Oh-Lyong Kim; Min-Su Kim; Seong-Ho Kim; Chul-Hoon Chang; Dai-Seg Bai
Journal:  J Korean Neurosurg Soc       Date:  2008-11-30

2.  Deficits in Visual System Functional Connectivity after Blast-Related Mild TBI are Associated with Injury Severity and Executive Dysfunction.

Authors:  Casey S Gilmore; Jazmin Camchong; Nicholas D Davenport; Nathaniel W Nelson; Randy H Kardon; Kelvin O Lim; Scott R Sponheim
Journal:  Brain Behav       Date:  2016-03-23       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.